Flt3 ligand is prestored in T-lymphocytes and is released in response to chemotherapy-induced stem cell depletion.

被引：0
|
作者：
Chklovskaia, E
Jansen, W
Nissen, C
Gratwohl, A
Lyman, SD
WodnarFilipowicz, A
机构：
[1] UNIV BASEL HOSP,DEPT RES,CH-4031 BASEL,SWITZERLAND
[2] IMMUNEX RES & DEV CORP,SEATTLE,WA 98101
来源：
EXPERIMENTAL HEMATOLOGY | 1997年 / 25卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：385 / 385
页数：1
相关论文
共 50 条
  • [1] GENERATION AND CHARACTERIZATION OF FLT3 LIGAND-CONTAINING CHIMERIC ANTIGEN RECEPTOR (CAR) T-LYMPHOCYTES
    Pratap, Suraj
    Zhao, Wanke
    Ho, Tina
    Zhao, Joe
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [2] Increased production of FLT3 ligand in leukemia patients with chemotherapy-induced bone marrow suppression
    Chklovskaia, E
    Lyman, SD
    Jansen, W
    Nissen, C
    WodnarFilipowicz, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 782 - 782
  • [3] Mechanism of flt3 ligand expression in bone marrow failure: Translocation from intracellular stores to the surface of T lymphocytes after chemotherapy-induced suppression of hematopoiesis
    Chklovskaia, E
    Jansen, W
    Nissen, C
    Lyman, SD
    Rahner, C
    Landmann, L
    Wodnar-Filipowicz, A
    BLOOD, 1999, 93 (08) : 2595 - 2604
  • [4] Chronic expression of membrane-bound FLT3 ligand by T-lymphocytes in severe aplastic anemia.
    Pfister, O
    Chklovskaia, E
    Jansen, W
    Nissen, C
    Lyman, SD
    Wodnar-Filipowicz, A
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 747 - 747
  • [5] Preventing chemotherapy-induced myelosuppression by repurposing the FLT3 inhibitor quizartinib
    Taylor, Samuel J.
    Duyvestyn, Johanna M.
    Dagger, Samantha A.
    Dishington, Emma J.
    Rinaldi, Catherine A.
    Dovey, Oliver M.
    Vassiliou, George S.
    Grove, Carolyn S.
    Langdon, Wallace Y.
    SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (402)
  • [6] Flt3 ligand level reflects hematopoietic progenitor cell function in aplastic anemia and chemotherapy-induced bone marrow aplasia
    WodnarFilipowicz, A
    Lyman, SD
    Gratwohl, A
    Tichelli, A
    Speck, B
    Nissen, C
    BLOOD, 1996, 88 (12) : 4493 - 4499
  • [7] Cyclosporin a inhibits the release of FLT3 ligand from human T lymphocytes.
    Chklovskaia, E
    Pfister, O
    Dalle Carbonare, V
    Dominguez, J
    Rahner, C
    Nissen, C
    Wodnar-Filipowicz, A
    EXPERIMENTAL HEMATOLOGY, 1999, 27 (07) : 101 - 101
  • [8] The FLT3 Inhibitor Quizartinib Provides a Novel Strategy to Inhibit Chemotherapy-Induced Myelosuppression
    Langdon, Wallace Y.
    Taylor, Samuel J.
    Duyvestyn, Johanna M.
    Dagger, Samantha A.
    Vassiliou, George S.
    Grove, Carolyn S.
    BLOOD, 2016, 128 (22)
  • [9] Preclinical Evaluation of Flt3 Ligand to Improve T Cell Adaptive Immune Response During Sepsis
    Patil, Naeem K.
    Bohannon, Julia K.
    Luan, Liming
    Guo, Yin
    Sherwood, Edward R.
    FASEB JOURNAL, 2016, 30
  • [10] Serum Flt3 ligand variation as a predictive indicator of hematopoietic stem cell mobilization
    Haidar, JH
    Bazarbachi, A
    Mahfouz, R
    Haidar, HA
    Jaafar, H
    Daher, R
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2002, 11 (03): : 533 - 538
12345